Skip to contentN
Neogenomics Inc
N
NEONeogenomics Inc Q1 2019 · 10-Q
Revenue$95.58M$95.58M+50.7% vs Q1 2018 Net Income-$2.42M-$2.42MN/M vs Q1 2018 EPS Diluted-$0.03-$0.03N/M vs Q1 2018 Gross Profit$47,115,000+72.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
Operating Cash Flow$6,097,000−57.4% Free Cash Flowderived$2,901,000−69.9% Margins · derivedGross margin49.3%+6.2 pt vs Q1 2018
Operating margin2.7%−1.3 pt vs Q1 2018
Net margin-2.5%−3.6 pt vs Q1 2018
ended Mar 31, 2019 · filed May 8, 2019 · 38 d after period end